A new strategic partnership for Love Lifesciences is expected to leverage its core product — a safe, self-administered injection medication delivery system — to new groups of like-minded, innovation-first companies, said Nick Love.
The Overland Park biotech startup on Wednesday announced the deal with the Alliance for Pharmacy Compounding (APC), a leading trade organization, to advance patient care by promoting Love Lifesciences’ flagship UniPen device to APC’s more than 200 member pharmacies.
UniPen is a versatile safety injection device designed for a wide range of self-administered injectable therapies, including such popular treatments as GLP-1 agonists, testosterone, and other injectables commonly produced by compounding pharmacies.
Love Lifesciences will provide APC member pharmacies access to UniPen at industry-best pricing, said Love, CEO and co-founder of the company alongside Bradley Hopper.
“APC’s support for UniPen and Love Lifesciences further signifies the direction that the compounding pharmacy industry is moving forward with by integrating new innovations to target improvements to …